Human Metabolome Technologies (TSE:6090) Debt-to-Equity : 0.12 (As of Mar. 2024)

Human Metabolome Technologies Debt-to-Equity Chart

Human Metabolome Technologies Annual Data
	Trend	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Jun20	Jun21	Jun22
Debt-to-Equity		Get a 7-Day Free Trial					0.02	0.02	0.02	0.12	0.16

Human Metabolome Technologies Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.13	0.13	0.14	0.12	0.12

Competitive Comparison of Human Metabolome Technologies's Debt-to-Equity

For the Diagnostics & Research subindustry, Human Metabolome Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Human Metabolome Technologies's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Human Metabolome Technologies's Debt-to-Equity falls into.

Human Metabolome Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Human Metabolome Technologies's Debt to Equity Ratio for the fiscal year that ended in Jun. 2022 is calculated as

Human Metabolome Technologies's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies  (TSE:6090) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Human Metabolome Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Human Metabolome Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Human Metabolome Technologies (TSE:6090) Business Description